As of 2025-03-17, the EV/EBITDA ratio of Codiak BioSciences, Inc. (CDAK) is 0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDAK's latest enterprise value is -21.30 mil USD. CDAK's TTM EBITDA according to its financial statements is -62.43 mil USD. Dividing these 2 quantities gives us the above CDAK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 15.8x | 14.9x |
| Forward P/E multiples | 22.9x - 33.2x | 24.9x |
| Fair Price | (16.79) - (11.48) | (14.54) |
| Upside | -29553.8% - -20234.3% | -25600.9% |
| Date | EV/EBITDA |